Call for Papers  

Article Details

Research Article

Unveiling the Structural Insights into the Selective Inhibition of Protein Kinase D1

[ Vol. 25 , Issue. 10 ]


Raju Dash*, Md. Arifuzzaman, Sarmistha Mitra, Md. Abdul Hannan, Nurul Absar and S.M. Zahid Hosen*   Pages 1059 - 1074 ( 16 )


Background: Although protein kinase D1 (PKD1) has been proved to be an efficient target for anticancer drug development, lack of structural details and substrate binding mechanisms are the main obstacles for the development of selective inhibitors with therapeutic benefits.

Objective: The present study described the in silico dynamics behaviors of PKD1 in binding with selective and non-selective inhibitors and revealed the critical binding site residues for the selective kinase inhibition.

Methods: Here, the three dimensional model of PKD1 was initially constructed by homology modeling along with binding site characterization to explore the non-conserved residues. Subsequently, two known inhibitors were docked to the catalytic site and the detailed ligand binding mechanisms and post binding dyanmics were investigated by molecular dynamics simulation and binding free energy calculations.

Results: According to the binding site analysis, PKD1 serves several non-conserved residues in the G-loop, hinge and catalytic subunits. Among them, the residues including Leu662, His663, and Asp665 from hinge region made polar interactions with selective PKD1 inhibitor in docking simulation, which were further validated by the molecular dynamics simulation. Both inhibitors strongly influenced the structural dynamics of PKD1 and their computed binding free energies were in accordance with experimental bioactivity data.

Conclusion: The identified non-conserved residues likely to play critical role on molecular reorganization and inhibitor selectivity. Taken together, this study explained the molecular basis of PKD1 specific inhibition, which may help to design new selective inhibitors for better therapies to overcome cancer and PKD1 dysregulated disorders.


PKD1, ligand binding mechanism, molecular docking, molecular dynamics simulation, inhibitors, homology modeling.


Department of Biochemistry and Biotechnology, University of Science and Technology, Chittagong-4202, College of Pharmacy, Yeungnam University, Gyeongsan-38541, Plasma Bioscience Research Center, Plasma-bio display, Kwangwoon University, Seoul, 01897, Department of Anatomy, Dongguk University Graduate School of Medicine, Gyeongju 38066, Department of Biochemistry and Biotechnology, University of Science and Technology, Chittagong-4202, Molecular Modeling and Drug Design Laboratory, Pharmacology Research Division, Bangladesh Council of Scientific and Industrial Research, Chittagong-4220

Read Full-Text article